Daré Bioscience, Inc.
DARE
$1.92
$0.073.78%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -108.08% | 59.53% | 11.30% | 8.26% | 20.49% |
| Total Depreciation and Amortization | 3.78% | 10.89% | 4.74% | 162.02% | 2,643.75% |
| Total Amortization of Deferred Charges | -- | -209.33% | 2,206.78% | -- | -- |
| Total Other Non-Cash Items | 54.76% | -35.45% | -3.96% | 27.17% | -33.60% |
| Change in Net Operating Assets | -274.58% | 9.61% | 177.49% | -40.99% | -117.40% |
| Cash from Operations | -482.23% | 426.69% | 91.84% | 0.97% | -203.10% |
| Capital Expenditure | -- | -18.26% | -213.89% | 197.52% | 72.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -18.26% | -213.89% | 197.52% | 72.05% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -103.99% | 8.87% | -11.36% | -178.47% | 0.00% |
| Issuance of Common Stock | -92.56% | -93.20% | 3,846.11% | 8.90% | 685.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 91.14% | -- | -- | 200.00% | 96.86% |
| Cash from Financing | -268.71% | -97.73% | 42,680.37% | -117.76% | 216.71% |
| Foreign Exchange rate Adjustments | 273.15% | -472.46% | -46.51% | -1.53% | 119.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -478.44% | -90.93% | 440.70% | 1.36% | -220.21% |